D89.41
Monoclonal mast cell activation syndrome
Clinical Classification Guidelines
Medical Intelligence & Overview
Monoclonal Mast Cell Activation Syndrome (MCAS) is a rare condition characterized by the abnormal activation and proliferation of mast cells, which are a type of immune cell involved in allergic responses. Unlike typical allergies, MCAS is associated with a monoclonal population of mast cells, meaning these cells originate from a single abnormal clone. This syndrome can cause a wide range of symptoms due to the excessive release of mediators, such as histamine, from the overactive mast cells. Proper recognition and management are essential to improving quality of life for affected individuals.
Causes & Symptoms
Clinical Causes: Clonal expansion of abnormal mast cells producing excess mediators Genetic mutations leading to the proliferation of monoclonal mast cells Associated hematologic disorders, such as systemic mastocytosis Unknown environmental triggers that may activate or worsen symptoms Potential hereditary predisposition affecting mast cell regulation
Key Symptoms: Flushing and skin redness Itching and hives (urticaria) Swelling of the lips, tongue, or throat Gastrointestinal discomfort such as nausea, diarrhea, or abdominal pain Difficulty breathing or wheezing Dizziness or lightheadedness, especially upon standing Rapid heartbeat (tachycardia) Low blood pressure during episodes Anaphylaxis in severe cases
Diagnostic & Treatment
Diagnosis Path: Detailed patient history documenting episodes of allergic-like symptoms Blood tests to measure serum tryptase levels during and between episodes Bone marrow biopsy to identify clonal mast cell populations Serum and urine tests to detect elevated mediators such as histamine and prostaglandins Molecular testing for mutations associated with clonality, like the KIT D816V mutation Exclusion of other disorders with similar symptoms, such as systemic mastocytosis or other allergic conditions
Treatment Protocols: Antihistamines (H1 and H2 blockers) to control allergic symptoms Mast cell stabilizers like cromolyn sodium to prevent mediator release Leukotriene receptor antagonists for symptom relief Avoidance of known triggers, including certain foods, medications, and environmental factors Emergency medications such as epinephrine for severe reactions Medications targeting underlying clone, such as tyrosine kinase inhibitors, in specific cases Regular monitoring by healthcare professionals to adjust treatment plans
Clinical Advice & FAQs
Billing Guidance
Is D89.41 a billable ICD-10 code?
Yes, D89.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D89.41?
Clinical documentation must specify the nature of Monoclonal mast cell activation syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference